A News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

A

Mkt Cap

$48.75B

Volume

1.30M

Next Earnings

November 23rd

Loading chart

A

AAgilent Technologies Inc.

A

Pay with—

Available Balance0.00

A

Mkt Cap

$48.77B

Volume

1.30M

Next Earnings

November 23rd

Chart Financials Earnings News About Dividends Insider Filings

Should You Invest in the First Trust Water ETF (FIW)?The First Trust Water ETF (FIW) is a passively managed fund with $1.71 billion in assets that tracks the ISE Clean Edge Water Index. It has a 0.5% expense ratio and 0.76% dividend yield. The fund has declined 3.23% year-to-date and 7.75% over the past year, with a beta of 0.99 indicating medium risk. It carries a Zacks ETF Rank of 3 (Hold) and is compared to alternative water ETFs like CGW and PHO.Zacks Investment Research · Oct 9, 2026

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGRThe global immunogenomics market is projected to grow from USD 6.32 billion in 2025 to USD 9.82 billion by 2033, expanding at a CAGR of 5.97%. Growth is driven by advancements in next-generation sequencing technologies, increasing demand for personalized medicine, and rising prevalence of immune-related disorders. Key applications include oncology, infectious disease research, vaccine development, and autoimmune disorder studies, with adoption across hospitals, diagnostic laboratories, pharmaceutical companies, and academic institutions.GlobeNewswire Inc. · Oct 5, 2026

Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion OpportunityThe global oligonucleotide synthesis reagents market is valued at USD 723.3 million in 2025 and is projected to reach USD 1.75 billion by 2033, growing at a 11.9% CAGR. Growth is driven by increasing demand for nucleic acid-based therapeutics including siRNA, antisense oligonucleotides, CRISPR gene editing, and mRNA platforms across oncology, rare genetic disorders, and infectious diseases.GlobeNewswire Inc. · Oct 5, 2026

Magnetic Beads Market - Global Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 BillionThe global magnetic beads market is projected to grow from USD 3.90 billion in 2026 to USD 6.18 billion by 2032, driven by automation, molecular diagnostics, genomics, and bioprocessing applications. Key growth drivers include adoption of automated magnetic separation platforms, advanced surface chemistries, AI-enabled workflow optimization, and expanding diagnostics capacity across regions. Strategic priorities for industry leaders include developing application-specific chemistries, strengthening supply-chain resilience, and leveraging AI analytics.GlobeNewswire Inc. · Oct 5, 2026

Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?Medtronic reported strong Q1 fiscal 2027 results with adjusted EPS of $1.45 (up 15.1% YoY) and revenues of $9.76 billion (up 13.7% YoY), both beating consensus estimates. The company raised full-year organic revenue growth guidance to 7.25%-7.75% and adjusted EPS guidance to $5.94-$6.00. However, shares have declined 6.4% since the earnings report, underperforming the S&P 500. Analyst estimates have trended downward post-earnings, and the stock carries a Zacks Rank #3 (Hold) rating.Zacks Investment Research · Oct 1, 2026

If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth NowA $1,000 investment in Agilent Technologies made in September 2016 would be worth $3,583.89 as of September 23, 2026, representing a 258.39% gain. This outperforms the S&P 500's 256.64% return over the same period. Analysts expect continued upside driven by instrument replacement demand, pharma exposure, and expanding specialty CDMO activity, though headwinds remain in academia, government, Europe, and China.Zacks Investment Research · Sep 23, 2026

Global Metabolomics Market to Reach US$9.01 Billion by 2035 as Precision Medicine, Biomarker Discovery and Advanced Analytics Unlock New OpportunitiesThe global metabolomics market is projected to grow from USD 2.81 billion in 2025 to USD 9.01 billion by 2035, expanding at a CAGR of 12.36%. Growth is driven by precision medicine, biomarker discovery, and multiomics adoption, with oncology accounting for over 44% of the market. However, Q1 2026 faced challenges from geopolitical tensions, supply chain disruptions, and elevated logistics costs affecting laboratory budgets and procurement timelines.GlobeNewswire Inc. · Sep 22, 2026

Magnetic Bead Purification Kits Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share OutlookThe global magnetic bead purification kits market reached $4.08 billion in 2025 with an 11.6% CAGR and is projected to grow to $6.73 billion by 2030 (10.5% CAGR) and $10.42 billion by 2035 (9.1% CAGR). Growth is driven by expanding genomics research, molecular diagnostics, and high-throughput screening. Semi-automated kits dominate at 51.8% market share, while Asia-Pacific is the fastest-growing region at 12% CAGR. Key challenges include skilled labor shortages and automation infrastructure dependencies.GlobeNewswire Inc. · Sep 21, 2026

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market ShareThe global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with 34% market share, while Asia Pacific is the fastest-growing region at 15.5% CAGR. Consumables dominate with 68% market share, and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, and laboratory automation.GlobeNewswire Inc. · Sep 4, 2026

International Markets and Agilent (A): A Deep Dive for InvestorsAgilent Technologies reported Q3 2026 total revenue of $1.88 billion, up 8.1% year-over-year. Europe contributed $504 million (26.8%), missing analyst expectations by 3.24%, while Asia Pacific delivered $613 million (32.6%), beating estimates by 3.15%. The company holds a Zacks Rank #3 (Hold) rating, with stock gaining 11.2% over the past month versus the S&P 500's 3.9% increase.Zacks Investment Research · Aug 31, 2026

to start trading

A

AAgilent Technologies Inc.

A

Pay with—

Available Balance0.00

Your PositionYou don't own any A yet.

Related Tickers

Earnings

Dividends

Last · Oct 6Quarterly

Amount$0.26

Yield0.59%

Annual$1.02